Fontem Ventures – On World No Tobacco Day, Switching to Vaping Should Be an Option for All the World’s Smokers
Fontem Ventures, owner of vapour brand blu, today calls on the World Health Organisation (WHO) to recognise the growing evidence that vaping can make a significant contribution to tobacco harm reduction, ahead of World No Tobacco Day 2019 on May 31st .
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190529005659/en/
“Currently more than half the world’s population live in countries where vaping is either banned or exists in a regulatory grey area.” said Dr Nveed Chaudhary, Scientific & Regulatory Affairs Senior Manager at Imperial Brands, parent company of Fontem Ventures. “We believe the WHO could help by recognizing the science underlying tobacco harm reduction and the potential health benefits to millions of smokers by opening up new options to switch away from combustible tobacco.”
In countries like the US where vaping is recognised as an alternative for smokers, and vaping products are widely available, data shows smoking rates are falling rapidly1 .
“We are encouraged by China’s recent decision to create a products standards based regulatory framework for vaping2 , which would potentially enable hundreds of millions of smokers to access an alternative to combustible tobacco.” said Dr Chaudhary.
China, India and Indonesia combined have more than 430 million daily smokers, nearly 50% of the world’s total smoking population3 .
Article 1(d) of the WHO’s Framework Convention on Tobacco Control (FCTC) defines tobacco control as “a range of supply, demand and harm reduction strategies that aim to improve the health of a population by eliminating or reducing their consumption of tobacco products and exposure to tobacco smoke.”
E-vapour products contain no tobacco4 , and peer reviewed scientific evidence5 suggests that switching to e-vapour products will substantially reduce exposure to harmful toxicants6 found in combustible tobacco smoke.
About Fontem Ventures
Fontem Ventures BV, is the e-vapour business behind blu . Headquartered in Amsterdam, Fontem Ventures’ purpose is to drive electronic vaping technology forward, delivering a better alternative to smokers and vapers around the world. Fontem Ventures is a subsidiary of Imperial Brands plc.
2 https://ecigintelligence.com/china-issues-new-industry-standards-for-e-cigarettes-and-e-liquids/ (Subscription only)
5 Article 14 The WHO FCTC states that “each Party shall develop and disseminate appropriate, comprehensive and integrated guidelines based on scientific evidence and best practices, taking into account national circumstances and priorities, and shall take effective measures to promote cessation of tobacco use and adequate treatment for tobacco dependence” The body of scientific evidence supporting the harm reduction potential of vaping is now significant and a useful summary can be found here: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/457102/Ecigarettes_an_evidence_update_A_report_commissioned_by_Public_Health_England_FINAL.pdf
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
TX-RIVERSAND17.9.2019 07:02:05 CEST | Press release
Riversand Technologies Appoints New EVP to Lead Growth in Europe and Middle East
NY-THE-WE-COMPANY17.9.2019 04:59:08 CEST | Press release
Statement From The We Company
PSE17.9.2019 02:02:13 CEST | Press release
PSE plans to become part of Siemens
CA-VELODYNE-LIDAR17.9.2019 00:21:10 CEST | Press release
Velodyne Executive Addresses Why Lidar is Necessary for Safe Vehicle Automation at IAA 2019 Conference
VIRGIN-VOYAGES16.9.2019 22:34:07 CEST | Press release
Virgin Voyages Reveals High-fashion Uniform Collection Designed by Gareth Pugh With a Star-studded Celebration at London Fashion Week
VALBIOTIS16.9.2019 17:42:08 CEST | Press release
VALBIOTIS Presents Positive Results From a Study on TOTUM-63, Active Substance of VALEDIA®, Conducted by the CarMeN Laboratory in Lyon, at the Annual Meeting of the European Association for the Study of Diabetes (EASD)
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom